Amylyx Pharmaceuticals IncNASDAQ:AMLX
- LAST PRICE3.0850
- TODAY'S CHANGE (%)-0.1150 (-3.5938%)
- Bid / Lots3.0600/ 5
- Ask / Lots3.0900/ 1
- Open / Previous Close3.2500 / 3.2000
- Day Range
- 52 Week Range
- Volume763,161
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMLX |
|---|---|---|
| 09:32 ET | 28670 | 3.235 |
| 09:34 ET | 14383 | 3.235 |
| 09:36 ET | 700 | 3.2335 |
| 09:38 ET | 1400 | 3.265 |
| 09:39 ET | 1668 | 3.2649 |
| 09:41 ET | 3330 | 3.2605 |
| 09:43 ET | 7729 | 3.245 |
| 09:45 ET | 1891 | 3.235 |
| 09:48 ET | 14743 | 3.23 |
| 09:50 ET | 992 | 3.23 |
| 09:52 ET | 1386 | 3.21 |
| 09:54 ET | 100 | 3.2001 |
| 09:56 ET | 20654 | 3.205 |
| 09:57 ET | 1689 | 3.215 |
| 09:59 ET | 2653 | 3.2011 |
| 10:01 ET | 5239 | 3.205 |
| 10:03 ET | 419 | 3.205 |
| 10:06 ET | 9400 | 3.2 |
| 10:08 ET | 960 | 3.195 |
| 10:10 ET | 2779 | 3.195 |
| 10:12 ET | 2793 | 3.2094 |
| 10:14 ET | 249 | 3.21 |
| 10:15 ET | 1500 | 3.2046 |
| 10:17 ET | 100 | 3.205 |
| 10:19 ET | 166 | 3.2088 |
| 10:21 ET | 300 | 3.205 |
| 10:24 ET | 8288 | 3.195 |
| 10:26 ET | 1719 | 3.205 |
| 10:28 ET | 530 | 3.2085 |
| 10:30 ET | 100 | 3.2088 |
| 10:33 ET | 5425 | 3.1812 |
| 10:35 ET | 200 | 3.1808 |
| 10:37 ET | 6501 | 3.17 |
| 10:39 ET | 926 | 3.1711 |
| 10:42 ET | 450 | 3.175 |
| 10:46 ET | 300 | 3.175 |
| 10:48 ET | 3800 | 3.175 |
| 10:50 ET | 2133 | 3.175 |
| 10:51 ET | 1400 | 3.165 |
| 10:53 ET | 2300 | 3.165 |
| 10:55 ET | 2299 | 3.165 |
| 10:57 ET | 1338 | 3.19 |
| 11:00 ET | 1069 | 3.185 |
| 11:04 ET | 200 | 3.185 |
| 11:06 ET | 400 | 3.1888 |
| 11:08 ET | 700 | 3.1841 |
| 11:09 ET | 6319 | 3.165 |
| 11:11 ET | 4400 | 3.175 |
| 11:13 ET | 2000 | 3.1746 |
| 11:15 ET | 400 | 3.175 |
| 11:18 ET | 400 | 3.175 |
| 11:22 ET | 6508 | 3.19 |
| 11:24 ET | 3017 | 3.2 |
| 11:26 ET | 2000 | 3.19 |
| 11:27 ET | 1400 | 3.1901 |
| 11:29 ET | 800 | 3.195 |
| 11:31 ET | 100 | 3.19 |
| 11:36 ET | 500 | 3.1907 |
| 11:38 ET | 1312 | 3.185 |
| 11:40 ET | 863 | 3.1899 |
| 11:42 ET | 3000 | 3.1803 |
| 11:45 ET | 1604 | 3.189 |
| 11:47 ET | 2077 | 3.185 |
| 11:51 ET | 1144 | 3.175 |
| 11:54 ET | 3712 | 3.185 |
| 11:56 ET | 626 | 3.19 |
| 11:58 ET | 100 | 3.185 |
| 12:00 ET | 22370 | 3.185 |
| 12:02 ET | 6809 | 3.19 |
| 12:03 ET | 23694 | 3.19 |
| 12:05 ET | 22545 | 3.2005 |
| 12:07 ET | 1426 | 3.195 |
| 12:09 ET | 697 | 3.19 |
| 12:12 ET | 756 | 3.18 |
| 12:14 ET | 1000 | 3.1707 |
| 12:16 ET | 100 | 3.175 |
| 12:20 ET | 852 | 3.175 |
| 12:21 ET | 953 | 3.175 |
| 12:23 ET | 312 | 3.175 |
| 12:25 ET | 100 | 3.175 |
| 12:27 ET | 147 | 3.175 |
| 12:30 ET | 913 | 3.1799 |
| 12:32 ET | 2125 | 3.175 |
| 12:36 ET | 7571 | 3.165 |
| 12:38 ET | 200 | 3.165 |
| 12:39 ET | 100 | 3.165 |
| 12:41 ET | 500 | 3.16 |
| 12:43 ET | 8745 | 3.145 |
| 12:45 ET | 6278 | 3.145 |
| 12:48 ET | 200 | 3.145 |
| 12:50 ET | 550 | 3.135 |
| 12:52 ET | 575 | 3.13 |
| 12:54 ET | 10480 | 3.1131 |
| 12:56 ET | 1050 | 3.115 |
| 12:57 ET | 300 | 3.11 |
| 12:59 ET | 7601 | 3.12 |
| 01:01 ET | 3653 | 3.115 |
| 01:03 ET | 3461 | 3.125 |
| 01:06 ET | 8838 | 3.13 |
| 01:08 ET | 6852 | 3.13 |
| 01:10 ET | 1345 | 3.14 |
| 01:12 ET | 2000 | 3.14 |
| 01:15 ET | 2187 | 3.125 |
| 01:17 ET | 726 | 3.115 |
| 01:19 ET | 700 | 3.12 |
| 01:21 ET | 500 | 3.125 |
| 01:24 ET | 10898 | 3.125 |
| 01:26 ET | 900 | 3.1345 |
| 01:28 ET | 700 | 3.135 |
| 01:30 ET | 2400 | 3.125 |
| 01:32 ET | 3367 | 3.135 |
| 01:33 ET | 3443 | 3.125 |
| 01:35 ET | 1600 | 3.115 |
| 01:37 ET | 600 | 3.115 |
| 01:39 ET | 2961 | 3.1 |
| 01:42 ET | 4694 | 3.095 |
| 01:44 ET | 200 | 3.095 |
| 01:46 ET | 3472 | 3.1 |
| 01:48 ET | 500 | 3.105 |
| 01:50 ET | 5819 | 3.105 |
| 01:51 ET | 100 | 3.105 |
| 01:53 ET | 7267 | 3.09 |
| 01:55 ET | 2300 | 3.095 |
| 01:57 ET | 1200 | 3.095 |
| 02:00 ET | 4000 | 3.095 |
| 02:02 ET | 18367 | 3.085 |
| 02:04 ET | 7992 | 3.085 |
| 02:06 ET | 3711 | 3.09 |
| 02:08 ET | 226 | 3.0901 |
| 02:09 ET | 258 | 3.095 |
| 02:11 ET | 800 | 3.085 |
| 02:13 ET | 499 | 3.085 |
| 02:15 ET | 14220 | 3.09 |
| 02:18 ET | 1016 | 3.0944 |
| 02:20 ET | 2499 | 3.08 |
| 02:22 ET | 500 | 3.075 |
| 02:24 ET | 5335 | 3.065 |
| 02:26 ET | 11985 | 3.06 |
| 02:27 ET | 6011 | 3.06 |
| 02:29 ET | 2500 | 3.065 |
| 02:31 ET | 1182 | 3.065 |
| 02:33 ET | 1149 | 3.065 |
| 02:36 ET | 700 | 3.065 |
| 02:38 ET | 3411 | 3.065 |
| 02:40 ET | 1018 | 3.065 |
| 02:42 ET | 2870 | 3.065 |
| 02:44 ET | 1300 | 3.065 |
| 02:45 ET | 1874 | 3.07 |
| 02:47 ET | 1489 | 3.075 |
| 02:49 ET | 1142 | 3.075 |
| 02:51 ET | 1465 | 3.07 |
| 02:54 ET | 2443 | 3.065 |
| 02:56 ET | 2420 | 3.065 |
| 02:58 ET | 8920 | 3.08 |
| 03:00 ET | 4165 | 3.0897 |
| 03:02 ET | 963 | 3.09 |
| 03:03 ET | 2500 | 3.095 |
| 03:05 ET | 3126 | 3.095 |
| 03:07 ET | 1057 | 3.1 |
| 03:09 ET | 828 | 3.095 |
| 03:12 ET | 13672 | 3.085 |
| 03:14 ET | 800 | 3.085 |
| 03:16 ET | 3486 | 3.085 |
| 03:18 ET | 2250 | 3.09 |
| 03:20 ET | 1600 | 3.09 |
| 03:21 ET | 1625 | 3.09 |
| 03:23 ET | 2637 | 3.095 |
| 03:25 ET | 1986 | 3.095 |
| 03:27 ET | 3286 | 3.085 |
| 03:30 ET | 3816 | 3.085 |
| 03:32 ET | 2628 | 3.085 |
| 03:34 ET | 1186 | 3.085 |
| 03:36 ET | 2436 | 3.085 |
| 03:38 ET | 1744 | 3.085 |
| 03:39 ET | 1400 | 3.085 |
| 03:41 ET | 1328 | 3.085 |
| 03:43 ET | 2582 | 3.085 |
| 03:45 ET | 3600 | 3.085 |
| 03:48 ET | 2131 | 3.085 |
| 03:50 ET | 3044 | 3.1 |
| 03:52 ET | 4849 | 3.095 |
| 03:54 ET | 7011 | 3.09 |
| 03:56 ET | 7437 | 3.11 |
| 03:57 ET | 7197 | 3.105 |
| 03:59 ET | 48832 | 3.085 |
Sep 16, 2024
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm, from 11:42AM ET on Monday Sep 16, 2024 by Dow Jones
11:42AM ET on Monday Sep 16, 2024 by Dow Jones
Aug 28, 2024
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences, from 8:30AM ET on Wednesday Aug 28, 2024 by Dow Jones
8:30AM ET on Wednesday Aug 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amylyx Pharmaceuticals Inc | 217.9M | -1.3x | --- |
Organogenesis Holdings Inc | 373.9M | -23.1x | --- |
Amarin Corporation PLC | 239.7M | -7.4x | --- |
Ironwood Pharmaceuticals Inc | 648.5M | 92.8x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Coherus BioSciences Inc | 122.1M | -2.6x | --- |
Company Information
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Contact Information
- Headquarters
- 43 THORNDIKE STREETCAMBRIDGE, MA, United States 02141
- Phone
- 617-682-0917
- Fax
- 302-636-5454
Executives
- Chair of the Board of Directors
- George Milne
- Co-Chief Executive Officer, Director
- Joshua Cohen
- Co-Chief Executive Officer, Director
- Justin Klee
- Chief Financial Officer
- James Frates
- Chief Legal Officer and General Counsel
- Gina Mazzariello
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $217.9M |
|---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
